share_log

Belite Bio Shares Are Trading Higher After the Company Announced LBS-007 Was Granted FDA Fast-track Designation Status for Acute Leukemia.

Benzinga ·  Nov 27 23:06
Belite Bio Shares Are Trading Higher After the Company Announced LBS-007 Was Granted FDA Fast-track Designation Status for Acute Leukemia.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment